Vince Luca
@vcluca1
Associate Member/Professor @MoffittCancerCenter | Structural Immunology & Protein Engineering
ID: 253222010
http://www.thelucalab.org 16-02-2011 20:17:08
578 Tweet
530 Followers
421 Following
Important comment from Aaron Ring. It is no secret that NIH-funded scientists license their technology to biotech companies, this accelerates clinical development and encourages innovation. We need better science communication so this is not surprising or sensationalized.
Please RT! 🚀 Thrilled to share that I’ve joined Harvard Medical School Harvard Medical School as an Asst. Professor and an Investigator at Brigham and Women's Hospital and the Mass General Brigham Gene and Cell Therapy Institute! 🎉 The AbuGoot lab with Jonathan Gootenberg will work on programmable biology, novel
bioRxiv Synthetic Biology Amazing! SNAGs' adaptability to biomarkers offers targeted therapy promise. The UAE is emerging as a biotech hub. Exciting times ahead! #Innovation
What an amazing structure of the full length HCV E1-E2 envelope protein! It’s been over a decade since I worked on HCV as a grad student - it’s a so exciting to see this problem solved. Congratulations Prentoe_Lab!
#ESMO24: Retrospective study suggests Covid mRNA vaccines may boost checkpoint inhibitor efficacy, doubling 3-year overall survival in advanced lung cancer patients and raising questions about the importance of cancer vaccine personalization. Endpoints News: endpts.com/esmo24-in-surp…
Do regular old Covid vaccines help make cancer immunotherapy more effective? A very interesting, kind of wild story from Ryan Cross the Science Boss, who digs into the retrospective (CAVEATS!) study, the biology behind it, why the mRNA mechanism itself might be working, and more: